Aller au contenu principal
Type
Decision
État
Actif

Share meeting

The Conference of the Parties,
Noting with appreciation the work of the Chemical Review Committee in its consideration of fenthion (ultra low volume formulations at or above 640 g active ingredient/L), in particular the technical quality and comprehensiveness of the draft decision guidance document for that chemical,
Having considered the recommendation of the Chemical Review Committee to make fenthion (ultra low volume formulations at or above 640 g active ingredient/L) subject to the prior informed consent procedure and accordingly to list it in Annex III to the Rotterdam Convention,
Taking into account that the Conference of the Parties is not yet able to reach consensus on whether to list fenthion (ultra low volume formulations at or above 640 g active ingredient/L),
Aware that the failure to reach consensus so far has caused concern in many Parties,
1.Decides that the agenda for the ninth meeting of the Conference of the Parties shall include further consideration of a draft decision to amend Annex III to the Rotterdam Convention to include the following chemical:
ChemicalRelevant CAS number(s)Category
Fenthion (ultra low volume formulations at or above 640 g active ingredient/L)55-38-9Severely hazardous pesticide formulation
2.Decides that the requirements set out in Article 6 of the Convention, including the criteria set out in part 3 of Annex IV to the Convention as referenced in paragraph 5 of Article 6, the requirements set out in paragraph 1 of Article 7 and the requirements set out in the first sentence of paragraph 2 of Article 7 on the process for listing in Annex III to the Convention have been met;
3.Encourages Parties to make use of all available information on fenthion (ultra low volume formulations at or above 640 g active ingredient/L) to assist others, in particular developing‑country Parties and Parties with economies in transition, to make informed decisions regarding the import and management of fenthion (ultra low volume formulations at or above 640 g active ingredient/L) and to inform other Parties of those decisions using the information exchange provisions laid down in Article 14.